Ocumension Therapeutics (HKG:1477)
Hong Kong
· Delayed Price · Currency is HKD 6.94
+0.20 (2.97%)
Mar 10, 2026, 1:27 PM HKT
Ocumension Therapeutics Revenue
Ocumension Therapeutics had revenue of 294.03M CNY in the half year ending June 30, 2025, with 183.55% growth. This brings the company's revenue in the last twelve months to 543.72M, up 75.23% year-over-year. In the year 2024, Ocumension Therapeutics had annual revenue of 417.31M with 69.38% growth.
Revenue (ttm)
543.72M CNY
Revenue Growth
+75.23%
P/S Ratio
9.22
Revenue / Employee
1.08M CNY
Employees
505
Market Cap
5.50B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Laekna | 5.07M |
| CARsgen Therapeutics Holdings | 139.84M |
| Jacobio Pharmaceuticals Group | 220.66M |
| Viva Biotech Holdings | 2.01B |
| Shandong Boan Biotechnology | 829.27M |
| Mirxes Holding Company | 166.32M |
| TYK Medicines | 117.25K |
| CK Life Sciences Int'l., (Holdings) | 5.49B |